Abstract
High reactive oxygen species (ROS), Ha-Ras, and active ERK1/2 in fibroblasts play an essential role in the pathogenesis of systemic sclerosis (SSc). The present study was carried out to evaluate the effects of the ethanol extract from fruits of Capparis Spinosa L. (ECS) on oxidative stress and ROS-ERK1/2-Ha-Ras signal loop in SSc dermal fibroblasts in vitro. Cultured dermal fibroblasts from three SSc patients and three normal controls were treated with ECS by different concentration (10, 50, 100 μg/ml). ECS significantly reduced the production of O2 –, H2O2, and ROS in SSc fibroblasts in a dose-dependent manner. ECS effectively minimized the loss of cell viability and apoptosis induced by H2O2 in normal and SSc fibroblasts. Furthermore, the protective effect of ECS on SSc fibroblasts was more significant than on normal ones. ECS decreased the expression of P-ERK1/2 and Ha-Ras in a dose-dependent manner. In conclusion, ECS exhibits a notable activity in protecting against oxidative stress and interrupting of ROS-ERK1/2-Ha-Ras signal loop in SSc, suggesting its potential protective effects against skin sclerosis.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Capparis spinosa L. belongs to the Capparidaceae Family. This green spiny shrub distributes throughout the Mediterranean basin and grows wildly in the north-west region of China. Apart from its use as flavoring, C. spinosa has been known as a traditional herbal medicine for its diuretic, antihypertensive and tonic properties for centuries [7]. Previous chemical studies have reported that alkaloids, lipids, polyphenols, flavonoids, indole and glucosinolates were isolated from C. spinosa [19, 22]. Various extracts of C. spinosa have been showed antifungal [1], anti-inflammatory [18], antiallergic [26], antihepatotoxic [12], anti-diabetic [10], and hypolipidemic effects [11]. The methanol extract of C. spinosa showed a noteworthy antioxidant/free radical scavenging effectiveness in various in vitro models [6, 13], and this extract has been suggested to treat oxidative stress-based pathological diseases.
Systemic sclerosis (SSc) is a connective tissue disorder that typically results in fibrosis of the skin and internal organs [5]. Although the pathogenesis of SSc is unknown, the pathologic increase in tissue collagen deposition in affected organs is mainly the result of its overproduction by dermal fibroblasts [14, 15]. Recently, it is proposed that excessive oxidative stress might be involved in the pathogenesis of SSc [20, 21, 25]. Fibroblasts derived from SSc patients contain high ROS and Ha-Ras levels and exhibit constitutive activation of ERK1/2. The activation of ROS-Ha-Ras-ERK1/2 loop in SSc fibroblasts lead to collagen over-synthesis. Inhibition of either ROS, or ERK1/2, or Ha-Ras converted SSc fibroblasts to normal ones [20, 25].
On the basis of the properties of the active compounds contained in C. spinosa, we presume that C. spinosa may have important clinical applications in scleroderma. We observed for the first time that the ethanol extract of C. spinosa (ECS) could significantly reduce the expression of α2(I) collagen mRNA and type I collagen protein in SSc fibroblast in a dose- and time-dependent manner [8]. In the present work we investigated the effects of the pool of active compounds contained in ECS on oxidative stress and the ROS-Ha-Ras-ERK1/2 loop in SSc fibroblasts.
Materials and methods
Reagents
Collagenase, Dulbecco’s modified Eagle’s medium (DMEM), fetal calf serum (FCS), l-glutamine, pancreatic trypsin were obtained from Gibco (Milan, Italy). Dimethylsulfoxide (DMSO), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide(MTT), N-acetyl-l-cysteine(NAC), ferricytochrome C, Superoxide dismutase, homovanilic acid, horseradish peroxidase were obtained from Sigma-Aldrich Co (St. Louis, MO, USA). Fluorescent probe 2′-7′-dichlorodihydrofluorescin diacetate (DCFH-DA) purchased from Molecular Probes (Eugene, OR, USA). Annexin V/PI assay kit purchased from Bender (Vienna, Austria). The bicinchoninic acid protein assay kit was from Pierce (Lockford, IL, USA). Anti-p-ERK1/2, anti-ERK1/2, anti-Ha-ras, anti-Ki-ras and antirabbit IgG horseradish peroxidase antibodies were purchased from Chemicon (CA, USA). Polyvinylidene difluoride membranes were from Millipore (Milford, MA). The chemiluminescence detection kit was acquired from Amersham Pharmacia (Arlington Heights, IL, USA).
Preparation of the extract of C. spinosa
Fruits of C. spinosa were collected from Xinjiang province in August 2006 and air-dried at 37°C. They were authenticated by Associate Professor Liurong Chen (College of Pharmaceutical Sciences, Zhejiang University, China). Voucher specimens (XJ0608) were deposited at the herbarium of Department of Dermatology, Second Affiliated Hospital, School of Medicine, Zhejiang University, China, for further reference. The fruits (100 g) were chopped into small pieces and then extracted twice with 95% ethanol (800 ml) by reflux at 80°C for 1 h and the solution pooled. The solution was filtered and evaporated to dryness under reduced pressure to obtain the extract 10.26 g. For in vitro tests, ECS was reconstituted in DMSO, sterilized with 0.22 μm filter and further diluted with serum-free medium to defined concentrations prior to use. The amount of total flavonoids in the ethanol extract was 5.439 ± 0.736% (w/w) (as rutin equivalents) determined by ultraviolet spectrophotometric analysis as described previously [9]. In addition, the level of rutin was calculated as 0.353 ± 0.007% (w/w) by HPLC analysis [13].
Primary fibroblasts
Human dermal fibroblasts were obtained from punch biopsies taken from the leading edge of affected areas (abdomen or dorsal forearm) of three early stage (<2 years) patients with diffuse cutaneous SSc, who fulfilled the American Rheumatism Association preliminary criteria for the diagnosis of SSc [24]. Control fibroblasts were obtained by skin biopsies from three age- and sex-matched healthy donors. SSc and control samples were processed at equal pace. Primary fibroblasts were maintained in 25 cm2 culture flasks in DMEM containing 10% FCS, 2 mM l-glutamine, 100 U/ml penicillin, and 100 mg/ml streptomycin. Monolayer cultures were incubated at 37°C in 5% CO2. Fibroblasts between the fourth and the sixth subpassage were used in all experiments. Confluent quiescent fibroblasts were treated with different concentrations of ECS (10, 50, 100 μg/ml) for 48 h.
ROS assay
The superoxide anion release from fibroblasts into the overlying medium was estimated using the superoxide dismutase-inhibitable cytochrome c reduction [21]. The hydrogen peroxide release was measured by a modified method described by Valletta and Berton [28]. The levels of reactive oxygen species (ROS) in living fibroblasts, loaded with fluorescent probe 2′-7-dichlorodihydrofluorescin diacetate (DCFH-DA) [17, 20], were observed under Olympus IX70 Inverted Microscope (Olympus, Middlesex, UK), and further measured by flow cytometric analysis using a FACS Calibur (BD Biosciences, San Jose, CA, USA). General ROS scavenger NAC (10 mM) was used as a reference compound.
Cell viability assay
The protective effect of ECS against the cytotoxic effect on normal and SSc fibroblasts induced by H2O2 was evaluated by MTT tests [16].The cells were incubated for 2 h with 6 mM H2O2 alone or pretreated for 48 h with different concentration of ECS, washed with PBS, and treated with 10 μl MTT dye. After 4 h incubation, the growth medium was removed and the formazan crystals were dissolved with 100 μl DMSO. The absorbance was quantified at 570 nm using an ELX800 Microplate Reader (Bio-Tek Instruments, Vermont, USA).
Apoptosis assay
The protective effect of ECS on the apoptosis of normal and SSc fibroblasts induced by H2O2 was evaluated by flow cytometric analysis. When grown to 80–90% confluence, fibroblasts were preincubated with 100 μg/ml ECS for 48 h followed by treatment with 2 mM H2O2 for 2 h. After the removal of the stimulus, apoptosis was detected by flow cytometric analysis using annexin V/PI assay kit.
Immunoblot analysis
After treatment, cytoplasmic extracts were lysed with lysis buffer containing 50 mM Tris–HCl, pH 7.5, 150 mM NaCl, 1 mMNa2EDTA, 1 mM EDTA, 1% Triton, 2.5 mM sodium pyrophosphate, 1 mM β-glycerophosphate, 1 mM Na3VO4, 1 mMNaF, 1 μg/ml leupeptin, and 1 mM phenylmethylsulfonyl fluoride. The concentration of protein extracts was determined using the bicinchoninic acid protein assay kit. Twenty micrograms of protein were separated in a 12% polyacrylamide gel and transferred onto Polyvinylidene difluoride membranes. After blocked for 2 h, the membranes were incubated with the following antibodies overnight at 4°C: anti-Ha-Ras (1:800), anti-Ki-Ras (1:800), anti-P-ERK1/2 (1:1000), anti-ERK1/2 (1:1000), and incubated with secondary antibodies (1:5,000) for 1 h at room temperature, then washed, visualized by the chemiluminescent assay, and quantitated using Gel-Pro 3.1 imaging software (Media Cybernetics, Silver Spring, MD).
Statistical analysis
Results are expressed as the mean ± SD. Statistical analysis using SPSS 11.0 software was carried out with one-way ANOVA followed by the Student-Newman–Keuls test for comparison between groups. P values less than 0.05 were considered to be significant.
Results
ECS reduces the release of O2 − and H2O2 in SSc fibroblasts
As shown in Fig. 1, The amounts of superoxide anion and H2O2 released by unstimulated SSc fibroblasts were significantly greater than those generated by normal ones. The levels of O2 − and H2O2 generated by normal fibroblasts did not change when the cells were treated with ECS and NAC. The treatment of SSc fibroblasts with ECS caused a dose-dependent inhibition on O2 − (Fig. 1a) and H2O2 (Fig. 1b) production. 10 mM NAC decreased O2 −and H2O2 production and these effects were similar to 100 μg/ml ECS.
ECS reduces the levels of ROS in SSc fibroblasts
The fluorescent probe DCFH-DA distributed within the different cell organelles, where it emitted according to the levels of intracellular ROS. The nuclear signal in normal fibroblasts was enhanced, whereas the cytoplasmic signal was reduced. The distribution pattern of the probe in quiescent SSc fibroblasts was as the same as in normal cells, but the signal was significantly higher, approaching saturation in both nuclear and perinuclear regions. After treatment with 100 μg/ml ECS, the fluorescent signal in SSc fibroblasts was markedly reduced to approximately the same as that in normal cells. This is also shown by treatment with 10 mM NAC (Fig. 2a). Trypan blue stain was used to demonstrate that 100 μg/ml ECS and 10 mM NAC did not cause cell death. The effect of different concentrations of ECS on the levels of ROS in living fibroblasts was further investigated as DCFH-DA fluorescence intensity by flow cytometric analysis. The levels of ROS in SSc fibroblasts were fourfold higher than that in normal controls. The treatment of SSc fibroblasts with ECS caused a dose-dependent inhibition in the ROS production. ECS at the dose of 100 μg/ml showed 49.30% inhibition, an antioxidant activity approximately equal to that of 10 mM NAC (51.24%) (Fig. 2b).
ECS protects against apoptosis and cell death induced by H2O2 in normal and SSc fibroblasts
MTT assay were performed to study the protective effect of ECS against the apoptotic death on normal and SSc fibroblasts induced by H2O2. Treatment with 6 mM H2O2 for 2 h, a high fraction of normal and SSc fibroblasts showed a decreased viability as compared to untreated controls. However, pretreatment with ECS at concentration of 10–100 μg/ml for 48 h before exposure to 6 mM H2O2 significantly prevented the loss of viability in a dose-dependent manner (Fig. 3a). Flow cytometric analysis was used to examine whether ECS protected against H2O2-induced apoptosis. A significant increase of apoptosis was observed in normal and SSc fibroblasts treated with 2 mM H2O2 as compared with control cells. SSc fibroblasts were more sensitive to oxidative stress-induced apoptosis than normal fibroblasts. However, ECS-pretreated fibroblasts showed significant resistance to H2O2-induced apoptosis. The protective effect of ECS on SSc fibroblasts was more significant than on normal fibroblasts (Fig. 3b, c).
ECS inhibits Ha-Ras expression and ERK/2 activation in SSc fibroblasts
After we confirmed that ECS can reduce the generation of ROS in SSc fibroblasts and protect them from H2O2-induced apoptosis, we further investigated the effects of this herbal extract on ROS-Ha-Ras-ERK1/2 loop. A significant increase of Ha-Ras protein and phosphorylated forms of ERK/2 was detected in SSc fibroblasts as compared with normal controls. After 48 h treatment, ECS significantly suppressed the protein levels of Ha-Ras and P-ERK1/2 in SSc fibroblasts in a dose-dependent manner (Fig. 4a, b).
Discussion
We have shown that ECS possessed a notable anti-fibrotic effects in SSc [8]. In the present work, we further investigated into mechanisms which might be implicated in the protective effects of ECS in vitro. It has been reported that low concentration of H2O2 could greatly stimulate the transcription of collagen genes in normal fibroblasts, suggesting ROS may be involved in the pathogenesis of SSc [25], Furthermore, the addition of ROS scavengers induced a dose-dependent down-regulation of a1(I) and a2(I) collagen genes in SSc [20]. Several reports have provided indirect [23] and direct [20, 21, 25] evidence of abnormal ROS generation in this disease. Our findings are consistent with previous reports that SSc fibroblasts release increased amounts of H2O2 and O2 − in vitro in the absence of stimulation. The generation of ROS in fibroblasts from SSc patients was significantly higher than those in normals. Although the antioxidant activity of extracts from C. spinosa has been reported in different in vitro tests, no report had been demonstrated before this study in terms of its effect on SSc fibroblasts. This study was undertaken to examine the effect of ethanol extract of C. spinosa on the production of ROS in SSc. To the best of our knowledge, the present study for the first time demonstrates that addition of this extract of natural compounds to SSc fibroblasts cultures could reduce the release of H2O2 and O2 −, and suppress production of ROS in a dose-dependent manner.
It has been recently found that platelet-derived growth factor (PDGF) and ROS induce Ha-Ras expression through ERK1/2 in primary fibroblasts. This has revealed a novel pathway, the ROS-ERK1/2-Ha-Ras signaling loop. This signaling loop is relatively amplified in fibroblasts in patients with SSc [25]. In SSc patients, an increased level of PDGF receptor resulting from abnormal TGF-β signaling [27] and stimulatory autoantibodies against PDGF receptor [4] triggers increased production of ROS by activation of NADPH oxidase [20]. ROS, in turn, activates the extracellular signal-regulated kinases 1 and 2(ERK1/2). Activation of ERK1/2 and high ROS levels stabilize Ha-Ras protein by inhibiting proteasomal degradation rather than change mRNA levels of Ha-Ras. The long-term persistence of Ras-ROS-ERK1/2 loop ultimately results in accumulating DNA damage, stimulating collagen-gene expression and becoming prone to stress-induced apoptosis. Inhibition of any of the components of this loop (ROS, ERK1/2, or Ras) down-regulates the system and restores the normal phenotype in SSc fibroblasts [25].
Consistent with previous reports, our experiments showed that SSc fibroblasts were more sensitive to oxidative stress-induced apoptosis than normal fibroblasts. Effects of ECS in vitro suggest it could be therapeutic by blocking oxidative stress in SSc. In this study, ECS in a range of 10–100 μg/ml remarkably inhibited the cytotoxicity of normal and SSc fibroblasts caused by H2O2. Moreover, Flow cytometry analysis using annexin V showed that ECS significantly reduced the apoptosis in H2O2 treated cells. This indicates that ECS at certain concentrations exerts a significantly protective effect by inhibiting H2O2-induced cell apoptosis and death. The protective effect of ECS on SSc fibroblasts was more significant than on normals. The present study demonstrated that fibroblasts derived from SSc patients exhibited high levels of Ha-Ras and constitutive activation of ERK1/2. Furthermore, the herbal extract, ECS, could significantly inhibit activation of ERK1/2 and expression of Ha-Ras protein in a dose-dependent manner. Since the association of Ras-ROS-ERK1/2 loop and collagen-gene expression has been well documented, our findings point out that ECS suppresses the expression of α2(I) collagen mRNA and type I collagen protein in SSc fibroblast, at least in part, through its antioxidant action and inhibition of the ROS- ERK1/2-Ras loop.
The pharmacological activities of ECS under our experimental conditions may be partially related to the high level of phenolic active constituents, especially flavonoids. Previous studies have reported that the methanol extract of C. spinosa is rich in flavonoid compounds such as quercetin derivatives (2.52% as rutin equivalents), kaempferol derivatives (3.28% as kaempferol-3-Orutinoside equivalents), and small amounts of hydroxycinnamic acids (caffeic acid, ferulic acid, p-cumaric acid, and cinnamic acid) [6]. The content of total flavonoids of ECS in our experiment was determined as 5.439 ± 0.736% (as rutin equivalents). The polyphenolic structures of flavonoids endow them with the ability of free radicals scavenge and transition metals chelation, a basis for their potent antioxidant abilities [3]. Flavonoids can interact with both lipid and protein components of biological membranes and alter their properties. They stabilize membranes by decreasing membrane fluidity [2]. The anti-apoptotic or cytoprotective action of flavonoids in ECS which prevent cell death caused by ROS is mainly associated to their protective effects on membranes. But active components, which are exactly responsible for the anti-fibrotic and antioxidant activity of ECS remain unknown, and await further research.
Abbreviations
- SSc:
-
Systemic sclerosis
- ECS:
-
The ethanol extract from fruits of Capparis Spinosa L.
- ROS:
-
Reactive oxygen species
- MTT:
-
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
- ERK:
-
Extracellular signal-regulated kinase
- DCFH-DA:
-
Fluorescent probe 2′-7′-Dichlorodihydrofluorescin diacetate
References
Ali-Shtayeh MS, Abu Ghdeib SL (1999) Antifungal activity of plant extracts against dermatophytes. Mycoses 42(11–12):665–672
Andrzej BH (2006) Flavonoid-membrane interactions: possible consequences for biological effects of some polyphenolic compounds. Acta Pharmacol Sin 27(1):27–40
Arora A, Byrem TM, Nair MG, Strasburg GM (2000) Modulation of liposomal membrane fluidity by flavonoids and isoflavonoids. Arch Biochem Biophys 373(1):102–109
Baroni SS, Santillo M, Bevilacqua F, Luchetti M, Spadoni T, Mancini M et al (2006) Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. N Engl J Med 354(25):2667–2676
Black CM, Stephen C (1993) Systemic sclerosis (scleroderma) and related disorders. In: Maddison PJ, Isenberg DA, Woo P, Glass DN (eds) Oxford textbook of rheumatology. Oxford University, Oxford, pp 771–789
Bonina F, Puglia C, Ventura D, Aquino R, Tortora S, Sacchi A et al (2002) In vitro antioxidant and in vivo photoprotective effects of a lyophilized extract of capparis spinosa L. buds. J Cosmet Sci 53(6):321–335
Calis I, Kuruuzum-Uz A, Ruedi P (1999) 1H-indole-3-acetonitrile glycosides from Capparis spinosa fruits. Phytochemistry 50:1205–1208
Cao YL, Li X, Zheng M (2008) Effect of Capparis spinosa on fibroblast proliferation and type I collagen production in progressive systemic sclerosis. Zhongguo Zhong Yao Za Zhi 33(5):560–563
Chinese Pharmacopoeia Commission (2005) Chinese pharmacopoeia part 1. People’s Health Press, Beijing, p 246
Eddouks M, Lemhadri A, Michel JB (2004) Caraway and caper potential anti-hyperglycaemic plants in diabetic rats. J Ethnopharmacol 94(1):143–148
Eddouks M, Lemhadri A, Michel JB (2005) Hyperlipidemic activity of aqueous extract of Capparis spinosa L. in normal and diabetic rats. J Ethnopharmacol 98(3):345–350
Gadgoli C, Mishra SH (1999) Antihepatotoxic activity of p-methoxy benzoic acid from Capparis spinosa. J Ethnopharmacol 66(2):187–192
Germanò MP, De Pasquale R, D’Angelo V, Catania S, Silvari V, Costa C (2002) Evaluation of extracts and isolated fraction from Capparis Spinosa L. buds as an antioxidant source. J Agric Food Chem 50(5):1168–1171
Jimenez SA, Feldman G, Bashey RI, Bienkowski R, Rosenbloom J (1986) Co-ordinate increase in the expression of type I and type III collagen genes in progressive systemic sclerosis. Biochem J 237:837–843
Kikuchi K, Smith EA, LeRoy EC, Trojanowska M (1992) Direct demonstration of transcriptional activation of collagen gene expression in systemic sclerosis fibroblasts. Biochem Biophys Res Commun 187:45–50
Mossmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63
Orlandini G, Ronda N, Gatti R, Gazzola GC, Borghetti A (1999) Receptor-ligand internalization. Methods Enzymol 307:340–350
Panico AM, Cardile V, Garufi F et al (2005) Protective effect of Capparis spinosa on chondrocytes. Life Sci 77(20):2479–2488
Rodrigo M, Lazaro MJ, Alvarruiz A, Giner V (1992) Composition of capers (Capparis spinosa): influence of cultivar, size and harvest date. J Food Sci 57:1152–1154
Sambo P, Baroni SS, Luchetti M, Paroncini P, Dusi S, Orlandini G et al (2001) Oxidative stress in scleroderma: maintenance of Scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway. Arthritis Rheum 44(11):2653–2664
Sambo P, Jannino L, Candela M, Salvi A, Donini M, Dusi S et al (1999) Monocytes of patients with systemic sclerosis (scleroderma) spontaneously release in vitro increased amounts of superoxide anion. J Invest Dermatol 112:78–84
Sharaf M, El-Ansari MA, Saleh NAM (2000) Quercetin triglycoside from Capparis spinosa. Fitoterapia 71:46–49
Stein CM, Tanner SB, Awad JA, Roberts LJ II, Morrow JD (1996) Evidence of free radical–mediated injury (isoprostane overproduction) in scleroderma. Arthritis Rheum 39:1146–1150
Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic, Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581–590
Svegliati S, Cancello R, Sambo P, Luchetti M, Paroncini P, Orlandini G et al (2005) Platelet-derived growth factor and reactive oxygen species (ROS) regulate Ras protein levels in primary human fibroblasts via ERK1/2. Amplification of ROS and Ras in systemic scleroderma fibroblasts. J Biol Chem 280(43):36474–36482
Trombetta D, Occhiuto F, Perri D, Puglia C, Santagati NA, Pasquale AD et al (2005) Antiallergic and antihistaminic effect of two extracts of Capparis spinosa L. flowering buds. Phytother Res 19(1):29–33
Yamakage A, Kikuchi K, Smith EA, LeRoy EC, Trojanowska M (1992) Selective upregulation of platelet-derived growth factor alpha receptors by transforming growth factor beta in scleroderma fibroblasts. J Exp Med 175(5):1227–1234
Valletta EA, Berton G (1987) Desensitization of macrophage oxygen metabolism on immobilized ligands: different effect of immunoglobulin G and complement. J Immunol 138:4366–4373
Acknowledgments
This work was supported by Provincial Natural Science Foundation of Zhejiang Province (Y2080357), and the Science and Technology Foundation of Zhejiang Province Project (2009C33135).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cao, Yl., Li, X. & Zheng, M. Capparis spinosa protects against oxidative stress in systemic sclerosis dermal fibroblasts. Arch Dermatol Res 302, 349–355 (2010). https://doi.org/10.1007/s00403-009-0998-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-009-0998-7